The comparison between peptides and anabolic steroids is common, and it confuses two very different categories of molecule with very different legal footing. For anyone comparing prescription-based providers, the classification matters more than the marketing. It determines whether a compound can be dispensed at all, who can dispense it, and how much oversight sits behind the bottle.
This piece sets the biology aside. What follows is about status, access, and cost, because those are the things you can actually act on when you sit down to choose a licensed provider.
The named peptides sit in different legal buckets
Two of the compounds most people ask about are approved drugs. Semaglutide and tirzepatide are FDA-approved GLP-1 medications sold under brand names by their manufacturers. Because they are approved and prescription-only, the cleanest path to them is a brand product filled at a licensed pharmacy with a valid prescription.
Tesamorelin is also FDA-approved for a specific indication and is prescription-only. That approval status is separate from the compounded versions of these molecules that some clinics offer, which exist under different rules and carry their own considerations.
The other two, semax and thymosin-alpha-1, are a different story in the United States. They are investigational and not FDA-approved as drugs here. Semax is used in some other countries, but that does not translate into approved status domestically, and availability claims should be read with that gap in mind.
How legitimate access actually works
For an approved drug, a licensed prescriber writes a prescription and a licensed pharmacy fills it. That is the whole legitimate chain. When a compound is not available as a brand product, or when a clinical reason supports it, a compounding pharmacy may prepare it. In the United States that happens through 503A pharmacies, which compound for individual patients, and 503B outsourcing facilities, which produce larger batches under stricter federal oversight.
What you should not treat as a purchase channel is a vendor selling material labeled research use only or not for human consumption. Those products sit outside the prescription system entirely. A legitimate provider connects you to a licensed pharmacy, not to a gray-market supplier.
You can review the individual compounds on their reference pages, including semaglutide, tirzepatide, tesamorelin, and semax.
What drives the cost
Price differences usually track a few concrete factors. Brand approved drugs carry manufacturer pricing and vary with insurance coverage. Compounded preparations are priced by the pharmacy and depend on the ingredient, the formulation, and the facility. Telehealth providers often bundle a consultation fee, follow-up, and the medication into one number, which can make apples-to-apples comparison harder.
When you compare quotes, separate the visit fee from the drug cost and ask which pharmacy fills the order. A low headline price that routes through an unlicensed source is not a bargain. It is a different product with no pharmacy accountability behind it.
How to vet a provider
The questions that matter are straightforward, and a legitimate provider will answer them without friction.
- Is there a real prescriber, licensed in your state, evaluating you before anything is dispensed?
- Which licensed pharmacy fills the prescription, and is it a 503A or 503B facility?
- For approved drugs, are you receiving the brand product or a compounded version, and why?
- Are the compounds they offer actually legal to dispense in the form described?
Steroid marketing and peptide marketing borrow the same language of transformation. The legal reality is more useful than the slogan. Some of these molecules are approved and routinely dispensed, some are compounded under specific rules, and some are investigational and not approved at all. Knowing which is which is the first real step in comparing providers honestly.